METHOD OF PURULENT CHOLANGITIS TREATMENT
FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to abdominal surgery, and is intended for purulent cholangitis treatment. The method includes draining and flushing of common bile duct with antiseptic agent. Miramistin solution is used as such agent, which is injected into co...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | IVANOV JURIJ BORISOVICH CHERNIKOV DMITRIJ ALEKSANDROVICH GRITSENKO VIKTOR ALEKSANDROVICH TRET'JAKOV ANATOLIJ ANDREEVICH |
| description | FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to abdominal surgery, and is intended for purulent cholangitis treatment. The method includes draining and flushing of common bile duct with antiseptic agent. Miramistin solution is used as such agent, which is injected into common bile duct 2-3 times a day during 3-10 days. ^ EFFECT: invention enables to avoid adverse cytotoxic effect on tissues of hepatobiliary system, improve efficiency of local antibiotic treatment of cholangitis, including due to increased sensitivity of cholangitis germs to endogenous antimicrobial peptide protein. ^ 2 ex, 3 tbl
Изобретение относится к медицине, в частности к абдоминальной хирургии, и предназначено для лечения гнойного холангита. Способ включает дренирование и промывание холедоха антисептическим средством. В качестве такого средства используют раствор мирамистина, который вводят в холедох 2-3 раза в сутки в течение 3-10 дней. Изобретение позволяет избежать отрицательного цитотоксического действия на ткани гепатобилиарной системы, повысить эффективность местной антибактериальной терапии холангита, в т.ч. за счет повышения чувствительности возбудителей холангита к эндогенному антимикробному белку тромбоцитов. 3 табл. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2404825C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2404825C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2404825C23</originalsourceid><addsrcrecordid>eNrjZNDwdQ3x8HdR8HdTCAgNCvVx9QtRcPbw93H0c_cM8QxWCAlydQzxBYryMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JL4oFAjEwMTCyNTZyNjIpQAAN0YJBE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD OF PURULENT CHOLANGITIS TREATMENT</title><source>esp@cenet</source><creator>IVANOV JURIJ BORISOVICH ; CHERNIKOV DMITRIJ ALEKSANDROVICH ; GRITSENKO VIKTOR ALEKSANDROVICH ; TRET'JAKOV ANATOLIJ ANDREEVICH</creator><creatorcontrib>IVANOV JURIJ BORISOVICH ; CHERNIKOV DMITRIJ ALEKSANDROVICH ; GRITSENKO VIKTOR ALEKSANDROVICH ; TRET'JAKOV ANATOLIJ ANDREEVICH</creatorcontrib><description>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to abdominal surgery, and is intended for purulent cholangitis treatment. The method includes draining and flushing of common bile duct with antiseptic agent. Miramistin solution is used as such agent, which is injected into common bile duct 2-3 times a day during 3-10 days. ^ EFFECT: invention enables to avoid adverse cytotoxic effect on tissues of hepatobiliary system, improve efficiency of local antibiotic treatment of cholangitis, including due to increased sensitivity of cholangitis germs to endogenous antimicrobial peptide protein. ^ 2 ex, 3 tbl
Изобретение относится к медицине, в частности к абдоминальной хирургии, и предназначено для лечения гнойного холангита. Способ включает дренирование и промывание холедоха антисептическим средством. В качестве такого средства используют раствор мирамистина, который вводят в холедох 2-3 раза в сутки в течение 3-10 дней. Изобретение позволяет избежать отрицательного цитотоксического действия на ткани гепатобилиарной системы, повысить эффективность местной антибактериальной терапии холангита, в т.ч. за счет повышения чувствительности возбудителей холангита к эндогенному антимикробному белку тромбоцитов. 3 табл.</description><language>eng ; rus</language><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101127&DB=EPODOC&CC=RU&NR=2404825C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101127&DB=EPODOC&CC=RU&NR=2404825C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IVANOV JURIJ BORISOVICH</creatorcontrib><creatorcontrib>CHERNIKOV DMITRIJ ALEKSANDROVICH</creatorcontrib><creatorcontrib>GRITSENKO VIKTOR ALEKSANDROVICH</creatorcontrib><creatorcontrib>TRET'JAKOV ANATOLIJ ANDREEVICH</creatorcontrib><title>METHOD OF PURULENT CHOLANGITIS TREATMENT</title><description>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to abdominal surgery, and is intended for purulent cholangitis treatment. The method includes draining and flushing of common bile duct with antiseptic agent. Miramistin solution is used as such agent, which is injected into common bile duct 2-3 times a day during 3-10 days. ^ EFFECT: invention enables to avoid adverse cytotoxic effect on tissues of hepatobiliary system, improve efficiency of local antibiotic treatment of cholangitis, including due to increased sensitivity of cholangitis germs to endogenous antimicrobial peptide protein. ^ 2 ex, 3 tbl
Изобретение относится к медицине, в частности к абдоминальной хирургии, и предназначено для лечения гнойного холангита. Способ включает дренирование и промывание холедоха антисептическим средством. В качестве такого средства используют раствор мирамистина, который вводят в холедох 2-3 раза в сутки в течение 3-10 дней. Изобретение позволяет избежать отрицательного цитотоксического действия на ткани гепатобилиарной системы, повысить эффективность местной антибактериальной терапии холангита, в т.ч. за счет повышения чувствительности возбудителей холангита к эндогенному антимикробному белку тромбоцитов. 3 табл.</description><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</subject><subject>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</subject><subject>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDwdQ3x8HdR8HdTCAgNCvVx9QtRcPbw93H0c_cM8QxWCAlydQzxBYryMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JL4oFAjEwMTCyNTZyNjIpQAAN0YJBE</recordid><startdate>20101127</startdate><enddate>20101127</enddate><creator>IVANOV JURIJ BORISOVICH</creator><creator>CHERNIKOV DMITRIJ ALEKSANDROVICH</creator><creator>GRITSENKO VIKTOR ALEKSANDROVICH</creator><creator>TRET'JAKOV ANATOLIJ ANDREEVICH</creator><scope>EVB</scope></search><sort><creationdate>20101127</creationdate><title>METHOD OF PURULENT CHOLANGITIS TREATMENT</title><author>IVANOV JURIJ BORISOVICH ; CHERNIKOV DMITRIJ ALEKSANDROVICH ; GRITSENKO VIKTOR ALEKSANDROVICH ; TRET'JAKOV ANATOLIJ ANDREEVICH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2404825C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2010</creationdate><topic>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</topic><topic>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</topic><topic>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>IVANOV JURIJ BORISOVICH</creatorcontrib><creatorcontrib>CHERNIKOV DMITRIJ ALEKSANDROVICH</creatorcontrib><creatorcontrib>GRITSENKO VIKTOR ALEKSANDROVICH</creatorcontrib><creatorcontrib>TRET'JAKOV ANATOLIJ ANDREEVICH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IVANOV JURIJ BORISOVICH</au><au>CHERNIKOV DMITRIJ ALEKSANDROVICH</au><au>GRITSENKO VIKTOR ALEKSANDROVICH</au><au>TRET'JAKOV ANATOLIJ ANDREEVICH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD OF PURULENT CHOLANGITIS TREATMENT</title><date>2010-11-27</date><risdate>2010</risdate><abstract>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to abdominal surgery, and is intended for purulent cholangitis treatment. The method includes draining and flushing of common bile duct with antiseptic agent. Miramistin solution is used as such agent, which is injected into common bile duct 2-3 times a day during 3-10 days. ^ EFFECT: invention enables to avoid adverse cytotoxic effect on tissues of hepatobiliary system, improve efficiency of local antibiotic treatment of cholangitis, including due to increased sensitivity of cholangitis germs to endogenous antimicrobial peptide protein. ^ 2 ex, 3 tbl
Изобретение относится к медицине, в частности к абдоминальной хирургии, и предназначено для лечения гнойного холангита. Способ включает дренирование и промывание холедоха антисептическим средством. В качестве такого средства используют раствор мирамистина, который вводят в холедох 2-3 раза в сутки в течение 3-10 дней. Изобретение позволяет избежать отрицательного цитотоксического действия на ткани гепатобилиарной системы, повысить эффективность местной антибактериальной терапии холангита, в т.ч. за счет повышения чувствительности возбудителей холангита к эндогенному антимикробному белку тромбоцитов. 3 табл.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; rus |
| recordid | cdi_epo_espacenet_RU2404825C2 |
| source | esp@cenet |
| subjects | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | METHOD OF PURULENT CHOLANGITIS TREATMENT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T22%3A55%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IVANOV%20JURIJ%20BORISOVICH&rft.date=2010-11-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2404825C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |